Analyses of inadequate incentives for pharmaceutical manufacturing innovation and FDA's countermeasuresYAO Li-xin, ZHENG Qiang1025-1036
Enlightenment for Chinese pharmaceutical industry from American first generics by way of Paragraph ⅣLIU Jian-feng, GU Dong-lei, DONG Lai-di, ZHU Lin, LUO Ma, XU Kuo1037-1043
Study on correlation between film thickness and dispersion uniformity of kang gong-yah dispersible tablet by near infrared spectroscopyWEN Wu-jiu, LUO Xiao-jian, ZHANG Yao, RAO Xiao-yong, YANG Xiao-mei, HE Yan1048-1056
Molecular simulation study of the effects of chlorobutanol and mannitolon on the stability of oxytocin solution under high temperatureLI Ya-nan, ZHANG Yuan, HE Qing, TAN De-jiang, MENG Fan-cui1057-1064
The pathogenesis of diabetic encephalopathy and the new progress of its drug therapyCAO Yue-ying, ZHAO Xin, PU Xiao-ping1065-1069
The study for activity detection method of recombinant human lysozymeLI Xiao-ying, GAO En, YANG Jin-fang, LI Min, YANG Xiao-lin, ZHAO Jin-li1070-1074
Research progress on key physical and chemical properties of injectionJIN Qian, GONG Wei, SU Zhi-de, WANG Yu-li, GAO Chun-sheng1075-1080
The development of the application of paclitaxel and gemcitabine co-delivery drug system and their anti-tumor mechanism studyLIU Yuan-fen, ZHOU Yong-mei1081-1086
Absorption, distribution, metabolism, excretion and toxicity of antibody-drug conjugates and its research progress on analytical approachesXU Ran-chi, MIAO Hong, ZHENG Jian-heng1087-1093